Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma

Objectives:To evaluate the efficacy and safety of transscleral cyclophotocoagulation (TS-CPC) limited to 180° of ciliary body ablation in patients with various forms of refractory glaucoma.Materials and Methods:Thirty eyes with refractory glaucoma treated with 180° TS-CPC were retrospectively analyz...

Full description

Bibliographic Details
Main Authors: Figen Bezci Aygün, Mehmet Cem Mocan, Sibel Kocabeyoğlu, Murat İrkeç
Format: Article
Language:English
Published: Galenos Yayinevi 2018-12-01
Series:Türk Oftalmoloji Dergisi
Subjects:
Online Access: http://www.oftalmoloji.org/archives/archive-detail/article-preview/efficacy-of-180-cyclodiode-transscleral-photocoagu/21061
_version_ 1797915224340168704
author Figen Bezci Aygün
Mehmet Cem Mocan
Sibel Kocabeyoğlu
Murat İrkeç
author_facet Figen Bezci Aygün
Mehmet Cem Mocan
Sibel Kocabeyoğlu
Murat İrkeç
author_sort Figen Bezci Aygün
collection DOAJ
description Objectives:To evaluate the efficacy and safety of transscleral cyclophotocoagulation (TS-CPC) limited to 180° of ciliary body ablation in patients with various forms of refractory glaucoma.Materials and Methods:Thirty eyes with refractory glaucoma treated with 180° TS-CPC were retrospectively analyzed for intraocular pressure (IOP) reduction and success rates. Patients’ age, gender, type of glaucoma, number of diode laser treatment sessions, postoperative complications, number of hypotensive medications required to control IOP, and best corrected visual acuity (BCVA) were evaluated. The criteria for success were defined as postoperative IOP <21 mmHg or >20% decrease in IOP with or without additional medical treatment.Results:The mean age of all patients was 51.3±26.9 years (range,1-84 years). The mean postoperative IOP level (23.9±8.5 mmHg) was significantly lower than preoperative IOP (39.2±8.9 mmHg) (p<0.001). The success rate was 66.6% after the first laser treatment and reached 86.7% following repeat laser treatments over an average follow-up period of 22.2±19.9 months. The need for topical hypotensive medications decreased from 2.8±1.0 preoperatively to 2.4±1.3 following TS-CPC (p=0.048). Two patients (6.6%) had a one-line decrease in their BCVA following TS-CPC. Transient hypotony and hyphema developed in 4 patients (13.3%). Total laser energy delivered did not correlate with either preoperative (rho=0.10; p=0.594) or postoperative IOP (rho=0.21; p=0.260).Conclusion:TS-CPC limited to 180° of ciliary body ablation is associated with a reasonable success rate and low incidence of adverse effects in patients with refractory glaucoma.
first_indexed 2024-04-10T12:38:17Z
format Article
id doaj.art-425c6b41bd014f48b817ad37398dd930
institution Directory Open Access Journal
issn 1300-0659
2147-2661
language English
last_indexed 2024-04-10T12:38:17Z
publishDate 2018-12-01
publisher Galenos Yayinevi
record_format Article
series Türk Oftalmoloji Dergisi
spelling doaj.art-425c6b41bd014f48b817ad37398dd9302023-02-15T16:14:28ZengGalenos YayineviTürk Oftalmoloji Dergisi1300-06592147-26612018-12-0148629930310.4274/tjo.1855913049054Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory GlaucomaFigen Bezci Aygün0Mehmet Cem Mocan1Sibel Kocabeyoğlu2Murat İrkeç3 Hacettepe Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye Hacettepe Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye Hacettepe Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye Hacettepe Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Ankara, Türkiye Objectives:To evaluate the efficacy and safety of transscleral cyclophotocoagulation (TS-CPC) limited to 180° of ciliary body ablation in patients with various forms of refractory glaucoma.Materials and Methods:Thirty eyes with refractory glaucoma treated with 180° TS-CPC were retrospectively analyzed for intraocular pressure (IOP) reduction and success rates. Patients’ age, gender, type of glaucoma, number of diode laser treatment sessions, postoperative complications, number of hypotensive medications required to control IOP, and best corrected visual acuity (BCVA) were evaluated. The criteria for success were defined as postoperative IOP <21 mmHg or >20% decrease in IOP with or without additional medical treatment.Results:The mean age of all patients was 51.3±26.9 years (range,1-84 years). The mean postoperative IOP level (23.9±8.5 mmHg) was significantly lower than preoperative IOP (39.2±8.9 mmHg) (p<0.001). The success rate was 66.6% after the first laser treatment and reached 86.7% following repeat laser treatments over an average follow-up period of 22.2±19.9 months. The need for topical hypotensive medications decreased from 2.8±1.0 preoperatively to 2.4±1.3 following TS-CPC (p=0.048). Two patients (6.6%) had a one-line decrease in their BCVA following TS-CPC. Transient hypotony and hyphema developed in 4 patients (13.3%). Total laser energy delivered did not correlate with either preoperative (rho=0.10; p=0.594) or postoperative IOP (rho=0.21; p=0.260).Conclusion:TS-CPC limited to 180° of ciliary body ablation is associated with a reasonable success rate and low incidence of adverse effects in patients with refractory glaucoma. http://www.oftalmoloji.org/archives/archive-detail/article-preview/efficacy-of-180-cyclodiode-transscleral-photocoagu/21061 Cyclophotocoagulationlaserglaucoma
spellingShingle Figen Bezci Aygün
Mehmet Cem Mocan
Sibel Kocabeyoğlu
Murat İrkeç
Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma
Türk Oftalmoloji Dergisi
Cyclophotocoagulation
laser
glaucoma
title Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma
title_full Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma
title_fullStr Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma
title_full_unstemmed Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma
title_short Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma
title_sort efficacy of 180° cyclodiode transscleral photocoagulation for refractory glaucoma
topic Cyclophotocoagulation
laser
glaucoma
url http://www.oftalmoloji.org/archives/archive-detail/article-preview/efficacy-of-180-cyclodiode-transscleral-photocoagu/21061
work_keys_str_mv AT figenbezciaygun efficacyof180cyclodiodetransscleralphotocoagulationforrefractoryglaucoma
AT mehmetcemmocan efficacyof180cyclodiodetransscleralphotocoagulationforrefractoryglaucoma
AT sibelkocabeyoglu efficacyof180cyclodiodetransscleralphotocoagulationforrefractoryglaucoma
AT muratirkec efficacyof180cyclodiodetransscleralphotocoagulationforrefractoryglaucoma